Literature DB >> 12970177

Crystal structure of the M1 protein-binding domain of the influenza A virus nuclear export protein (NEP/NS2).

Hatice Akarsu1, Wilhelm P Burmeister, Carlo Petosa, Isabelle Petit, Christoph W Müller, Rob W H Ruigrok, Florence Baudin.   

Abstract

During influenza virus infection, viral ribonucleoproteins (vRNPs) are replicated in the nucleus and must be exported to the cytoplasm before assembling into mature viral particles. Nuclear export is mediated by the cellular protein Crm1 and putatively by the viral protein NEP/NS2. Proteolytic cleavage of NEP defines an N-terminal domain which mediates RanGTP-dependent binding to Crm1 and a C-terminal domain which binds to the viral matrix protein M1. The 2.6 A crystal structure of the C-terminal domain reveals an amphipathic helical hairpin which dimerizes as a four-helix bundle. The NEP-M1 interaction involves two critical epitopes: an exposed tryptophan (Trp78) surrounded by a cluster of glutamate residues on NEP, and the basic nuclear localization signal (NLS) of M1. Implications for vRNP export are discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12970177      PMCID: PMC212717          DOI: 10.1093/emboj/cdg449

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  54 in total

1.  Structural plasticity in influenza virus protein NS2 (NEP).

Authors:  Barbara S Lommer; Ming Luo
Journal:  J Biol Chem       Date:  2001-12-20       Impact factor: 5.157

2.  Restriction of viral replication by mutation of the influenza virus matrix protein.

Authors:  Teresa Liu; Zhiping Ye
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

3.  Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons.

Authors:  A Nicholls; K A Sharp; B Honig
Journal:  Proteins       Date:  1991

4.  Nuclear transport of influenza virus ribonucleoproteins: the viral matrix protein (M1) promotes export and inhibits import.

Authors:  K Martin; A Helenius
Journal:  Cell       Date:  1991-10-04       Impact factor: 41.582

5.  Nuclear trafficking of influenza virus ribonuleoproteins in heterokaryons.

Authors:  G Whittaker; M Bui; A Helenius
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

6.  Nuclear import and export of influenza virus nucleoprotein.

Authors:  G Neumann; M R Castrucci; Y Kawaoka
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

7.  Structure of a bifunctional membrane-RNA binding protein, influenza virus matrix protein M1.

Authors:  B Sha; M Luo
Journal:  Nat Struct Biol       Date:  1997-03

8.  The kinetic mechanism of Ran--nucleotide exchange catalyzed by RCC1.

Authors:  C Klebe; H Prinz; A Wittinghofer; R S Goody
Journal:  Biochemistry       Date:  1995-10-03       Impact factor: 3.162

9.  Automated MAD and MIR structure solution.

Authors:  T C Terwilliger; J Berendzen
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1999-04

10.  Mechanism for inhibition of influenza virus RNA polymerase activity by matrix protein.

Authors:  K Watanabe; H Handa; K Mizumoto; K Nagata
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

View more
  93 in total

1.  Generation of influenza A virus NS2 (NEP) mutants with an altered nuclear export signal sequence.

Authors:  Kiyoko Iwatsuki-Horimoto; Taisuke Horimoto; Yutaka Fujii; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

2.  Plant actin-binding protein SCAB1 is dimeric actin cross-linker with atypical pleckstrin homology domain.

Authors:  Wei Zhang; Yang Zhao; Yan Guo; Keqiong Ye
Journal:  J Biol Chem       Date:  2012-02-22       Impact factor: 5.157

3.  Modeling the intracellular dynamics of influenza virus replication to understand the control of viral RNA synthesis.

Authors:  Frank S Heldt; Timo Frensing; Udo Reichl
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

4.  M Gene Reassortment in H9N2 Influenza Virus Promotes Early Infection and Replication: Contribution to Rising Virus Prevalence in Chickens in China.

Authors:  Juan Pu; Honglei Sun; Yi Qu; Chenxi Wang; Weihua Gao; Junda Zhu; Yipeng Sun; Yuhai Bi; Yinhua Huang; Kin-Chow Chang; Jie Cui; Jinhua Liu
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

5.  Human immunodeficiency virus rev-binding protein is essential for influenza a virus replication and promotes genome trafficking in late-stage infection.

Authors:  Amie J Eisfeld; Gabriele Neumann; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

6.  Structure-based design of NS2 mutants for attenuated influenza A virus vaccines.

Authors:  Hatice Akarsu; Kiyoko Iwatsuki-Horimoto; Takeshi Noda; Eiryo Kawakami; Hiroaki Katsura; Florence Baudin; Taisuke Horimoto; Yoshihiro Kawaoka
Journal:  Virus Res       Date:  2010-10-21       Impact factor: 3.303

7.  YRKL sequence of influenza virus M1 functions as the L domain motif and interacts with VPS28 and Cdc42.

Authors:  Eric Ka-Wai Hui; Subrata Barman; Dominic Ho-Ping Tang; Bryan France; Debi P Nayak
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

8.  In vitro and in vivo replication of influenza A H1N1 WSN33 viruses with different M1 proteins.

Authors:  Zhiguang Ran; Ying Chen; Huigang Shen; Xiaoxiao Xiang; Qinfang Liu; Bhupinder Bawa; Wenbao Qi; Laihua Zhu; Alan Young; Juergen Richt; Wenjun Ma; Feng Li
Journal:  J Gen Virol       Date:  2012-12-19       Impact factor: 3.891

9.  The respiratory syncytial virus matrix protein possesses a Crm1-mediated nuclear export mechanism.

Authors:  Reena Ghildyal; Adeline Ho; Manisha Dias; Lydia Soegiyono; Phillip G Bardin; Kim C Tran; Michael N Teng; David A Jans
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

10.  Compatibility among polymerase subunit proteins is a restricting factor in reassortment between equine H7N7 and human H3N2 influenza viruses.

Authors:  Chengjun Li; Masato Hatta; Shinji Watanabe; Gabriele Neumann; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.